Laura C. Zelarayán

1.9k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Laura C. Zelarayán is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Laura C. Zelarayán has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in Laura C. Zelarayán's work include Congenital heart defects research (13 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Laura C. Zelarayán is often cited by papers focused on Congenital heart defects research (13 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Laura C. Zelarayán collaborates with scholars based in Germany, United States and Spain. Laura C. Zelarayán's co-authors include Thomas Schimmang, Claudia Noack, Marı́a Teresa Alonso, Christina Gehrke, Eric Schoger, Rainer Dietz, Victor Vendrell, Yolanda Álvarez, Martin Bergmann and Mark Maconochie and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Laura C. Zelarayán

46 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice

2021 176 citations Eric Schoger, Laura C. Zelarayán et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura C. Zelarayán Germany	18	1.1k	308	224	134	134	48	1.4k
Vishwas Parekh United States	16	842 0.8×	80 0.3×	147 0.7×	168 1.3×	19 0.1×	49	1.6k
Claudio Graziano Italy	20	695 0.6×	183 0.6×	91 0.4×	325 2.4×	84 0.6×	77	1.2k
Tracey Lewis United States	14	927 0.8×	359 1.2×	86 0.4×	306 2.3×	24 0.2×	23	1.4k
Zehra Oya Uyguner Türkiye	20	823 0.7×	33 0.1×	66 0.3×	398 3.0×	214 1.6×	107	1.2k
Diego Fraidenraich United States	19	1.1k 1.0×	211 0.7×	167 0.7×	127 0.9×	14 0.1×	46	1.5k
Guilherme Lopes Yamamoto Brazil	18	732 0.7×	46 0.1×	271 1.2×	469 3.5×	42 0.3×	57	1.3k
Yvonne J. Vos Netherlands	19	520 0.5×	190 0.6×	103 0.5×	240 1.8×	7 0.1×	42	1.0k
Enrico Pierantozzi Italy	18	583 0.5×	173 0.6×	113 0.5×	43 0.3×	29 0.2×	32	842
Nara Sobreira United States	19	690 0.6×	46 0.1×	113 0.5×	671 5.0×	19 0.1×	61	1.3k
A Seller United Kingdom	15	940 0.9×	438 1.4×	100 0.4×	797 5.9×	19 0.1×	24	1.7k

Countries citing papers authored by Laura C. Zelarayán

Since Specialization

Citations

This map shows the geographic impact of Laura C. Zelarayán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura C. Zelarayán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura C. Zelarayán more than expected).

Fields of papers citing papers by Laura C. Zelarayán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura C. Zelarayán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura C. Zelarayán. The network helps show where Laura C. Zelarayán may publish in the future.

Co-authorship network of co-authors of Laura C. Zelarayán

This figure shows the co-authorship network connecting the top 25 collaborators of Laura C. Zelarayán. A scholar is included among the top collaborators of Laura C. Zelarayán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura C. Zelarayán. Laura C. Zelarayán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Streckfuß‐Bömeke, Katrin, N Kraenkel, Christoph Maack, et al.. (2024). Physiologists as medical scientists: An early warning from the German academic system. Physiological Reports. 12(21). e70055–e70055. 2 indexed citations

Schoger, Eric, Sebastian Kügler, Laura C. Zelarayán, et al.. (2024). Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants. Molecular Therapy — Nucleic Acids. 35(1). 102123–102123. 1 indexed citations

Sayour, Nabil V., Viktória É. Tóth, Zsófia Onódi, et al.. (2023). Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure-Overload-Induced Cardiac Dysfunction. International Journal of Molecular Sciences. 24(18). 13826–13826. 9 indexed citations

Schoger, Eric, Stephan von Haehling, Laura C. Zelarayán, et al.. (2023). Abstract P1128: CRISPR-mediated Activation Of DLK1 Induces A Regenerative State In Engineered Human Myocardium. Circulation Research. 133(Suppl_1).

Lerchenmüller, Carolin, Laura C. Zelarayán, Katrin Streckfuß‐Bömeke, et al.. (2023). Moving toward gender equity in the cardiology and cardiovascular research workforce in Germany: a report from the German Cardiac Society. European Heart Journal Open. 3(2). oead034–oead034. 4 indexed citations

Schoger, Eric, et al.. (2023). Combining a tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC). Stem Cell Research. 71. 103163–103163.

Schoger, Eric & Laura C. Zelarayán. (2022). Enhancing Cardiomyocyte Transcription Using In Vivo CRISPR/Cas9 Systems. Methods in molecular biology. 2573. 53–61. 2 indexed citations

Schoger, Eric, et al.. (2022). Tailoring Cardiac Synthetic Transcriptional Modulation Towards Precision Medicine. Frontiers in Cardiovascular Medicine. 8. 783072–783072. 2 indexed citations

Schoger, Eric, Wolfram‐Hubertus Zimmermann, Lukas Cyganek, & Laura C. Zelarayán. (2021). Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression. Stem Cell Research. 55. 102473–102473. 4 indexed citations

10.

Schoger, Eric, et al.. (2020). Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation. Stem Cell Research. 48. 101944–101944. 12 indexed citations

11.

Gross, Julia Christina & Laura C. Zelarayán. (2018). The Mingle-Mangle of Wnt Signaling and Extracellular Vesicles: Functional Implications for Heart Research. Frontiers in Cardiovascular Medicine. 5. 10–10. 27 indexed citations

12.

Noack, Claudia, et al.. (2017). Generation of a KLF15 homozygous knockout human embryonic stem cell line using paired CRISPR/Cas9n, and human cardiomyocytes derivation. Stem Cell Research. 23. 127–131. 5 indexed citations

13.

Kararigas, Georgios, Ba Tiep Nguyen, Laura C. Zelarayán, et al.. (2014). Genetic Background Defines the Regulation of Postnatal Cardiac Growth by 17β-Estradiol Through a β-Catenin Mechanism. Endocrinology. 155(7). 2667–2676. 28 indexed citations

14.

Zelarayán, Laura C., et al.. (2011). Hepoxilin A3 protects β-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811(6). 361–369. 12 indexed citations

15.

Vendrell, Victor, et al.. (2009). Tissue-specific requirements for FGF8 during early inner ear development. Mechanisms of Development. 126(10). 873–881. 20 indexed citations

16.

Zelarayán, Laura C., Claudia Noack, Christina Gehrke, et al.. (2009). NF- B activation is required for adaptive cardiac hypertrophy. Cardiovascular Research. 84(3). 416–424. 73 indexed citations

17.

Zelarayán, Laura C., Claudia Noack, Belaïd Sekkali, et al.. (2008). β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proceedings of the National Academy of Sciences. 105(50). 19762–19767. 104 indexed citations

18.

Zelarayán, Laura C., Victor Vendrell, Yolanda Álvarez, et al.. (2007). Differential requirements for FGF3, FGF8 and FGF10 during inner ear development. Developmental Biology. 308(2). 379–391. 82 indexed citations

19.

Wang, Xiuping, Marika Suomalainen, Szabolcs Felszeghy, et al.. (2007). An Integrated Gene Regulatory Network Controls Stem Cell Proliferation in Teeth. PLoS Biology. 5(6). e159–e159. 180 indexed citations

20.

Carnicero, Estela, Laura C. Zelarayán, Lukas Rüttiger, et al.. (2004). Differential roles of fibroblast growth factor‐2 during development and maintenance of auditory sensory epithelia. Journal of Neuroscience Research. 77(6). 787–797. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact